Roberto Bei Selected Research

Prostatic Neoplasms (Prostate Cancer)

3/2022	The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis.
1/2020	In vivo and in vitro inhibition of osteosarcoma growth by the pan Bcl-2 inhibitor AT-101.
3/2015	Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.
3/2013	Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Bei Research Topics

Disease

60	Neoplasms (Cancer) 02/2024 - 02/2007
12	Carcinoma (Carcinomatosis) 05/2020 - 11/2004
11	Malignant Mesothelioma 11/2023 - 11/2004
10	Breast Neoplasms (Breast Cancer) 11/2023 - 02/2007
10	Inflammation (Inflammations) 11/2020 - 03/2003
7	Carcinogenesis 12/2021 - 02/2007
6	Neoplasm Metastasis (Metastasis) 06/2023 - 09/2012
5	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2004
4	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 03/2013
4	Necrosis 01/2022 - 02/2007
4	Melanoma (Melanoma, Malignant) 12/2015 - 02/2008
4	Rupture 12/2006 - 03/2003
3	Neuroblastoma 01/2022 - 01/2021
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2007
3	Mesothelioma 04/2012 - 01/2008
3	Atherosclerotic Plaque (Atheroma) 12/2006 - 09/2003
3	Carotid Stenosis (Carotid Artery Stenosis) 12/2006 - 03/2003
2	Primary Effusion Lymphoma 03/2024 - 08/2013
2	Infarction (Infarctions) 01/2022 - 05/2017
2	Hypertension (High Blood Pressure) 11/2021 - 05/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2017
2	Glioma (Gliomas) 06/2018 - 01/2013
2	Ascites 01/2018 - 05/2017
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2017 - 05/2014
2	Osteoporosis 01/2017 - 03/2015
2	Colonic Neoplasms (Colon Cancer) 03/2015 - 07/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 12/2006
2	Infections 11/2012 - 01/2004
2	West Nile Fever 11/2012 - 04/2009
2	Wounds and Injuries (Trauma) 01/2010 - 07/2008
2	Ulcer 01/2010 - 07/2008
2	Gastroesophageal Reflux (GERD) 01/2010 - 07/2008
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2010 - 07/2008

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
12	PolyphenolsIBA 02/2024 - 01/2013
10	CytokinesIBA 11/2023 - 04/2008
8	ErbB Receptors (EGF Receptor)IBA 11/2023 - 11/2004
8	VaccinesIBA 01/2021 - 01/2010
8	AntigensIBA 01/2017 - 01/2008
7	CurcuminIBA 12/2023 - 01/2012
7	AntibodiesIBA 01/2017 - 11/2004
6	Matrix Metalloproteinases (MMPs)IBA 02/2024 - 03/2003
5	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2017
5	AutoantibodiesIBA 01/2020 - 12/2007
5	EpitopesIBA 03/2015 - 02/2007
4	ResveratrolIBA 12/2023 - 01/2012
4	Cancer VaccinesIBA 12/2022 - 01/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 09/2016
4	AntioxidantsIBA 10/2021 - 09/2011
4	Myelin P0 Protein (Myelin Protein Zero)IBA 03/2015 - 12/2007
3	Bortezomib (Velcade)FDA Link 03/2024 - 01/2021
3	Metalloproteases (Metalloproteinases)IBA 02/2024 - 09/2003
3	LigandsIBA 01/2023 - 01/2021
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2008
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2022 - 12/2006
3	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 01/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2008
3	GossypolIBA 01/2020 - 05/2017
3	Phosphotransferases (Kinase)IBA 06/2018 - 02/2008
3	FlavonoidsIBA 01/2017 - 09/2011
3	Protein Isoforms (Isoforms)IBA 06/2016 - 03/2003
3	lissamine rhodamine B (sulforhodamine B)IBA 06/2016 - 01/2011
3	Caspase 3 (Caspase-3)IBA 03/2015 - 01/2011
2	Phenobarbital (Luminal)FDA Link 11/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 02/2023 - 05/2022
2	NectinsIBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 12/2022 - 02/2016
2	Lipid NanoparticlesIBA 12/2022 - 08/2021
2	DNA VaccinesIBA 08/2022 - 07/2007
2	Oncogene Proteins (Oncogene Protein)IBA 08/2022 - 12/2021
2	EnzymesIBA 01/2022 - 06/2009
2	nutlin 3IBA 01/2022 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 09/2012
2	NF-kappa B (NF-kB)IBA 08/2021 - 01/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 09/2003
2	ProstaglandinsIBA 01/2021 - 03/2004
2	gossypol acetic acidIBA 01/2020 - 01/2018
2	AutoantigensIBA 01/2020 - 01/2017
2	ApigeninIBA 01/2017 - 01/2011
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2016 - 01/2013
2	Carcinoembryonic AntigenIBA 12/2015 - 09/2012
2	Trypan Blue FDA Link 03/2015 - 02/2008
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2013 - 07/2008
2	CollagenIBA 03/2013 - 01/2013
2	CateninsIBA 09/2012 - 11/2003
2	Epidermal Growth Factor (EGF)IBA 09/2012 - 11/2004
2	Cadherins (E-Cadherin)IBA 09/2012 - 11/2003
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 01/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 04/2011 - 01/2008
2	Peptides (Polypeptides)IBA 01/2010 - 07/2007
2	Sucralfate (Carafate)FDA LinkGeneric 01/2010 - 07/2008
2	5,7-dimethoxycoumarinIBA 06/2009 - 02/2008
2	Pemetrexed (MTA)FDA Link 04/2008 - 01/2008
2	Cisplatin (Platino)FDA LinkGeneric 04/2008 - 01/2008

Therapy/Procedure

16	Therapeutics 02/2024 - 01/2008
8	Immunotherapy 01/2023 - 09/2012
4	Radiotherapy 12/2021 - 11/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2008
3	Endarterectomy (Thromboendarterectomy) 12/2006 - 03/2003